Greystone Associates, May 2009, Pages: 100
Inhaled CNS Therapeutics - Markets & Opportunities Delivering drugs to the central nervous system presents unique challenges. But, drug developers and researchers have discovered that delivering CNS
Jain PharmaBiotech, May 2012, Pages: 633
, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiplesclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
with high bioavailability
- Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
- Device for the treatment of Barrett's esophagus and prevention